Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-023617
Filing Date
2022-08-19
Accepted
2022-08-19 17:00:27
Documents
1
Period of Report
2022-08-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 18805
  Complete submission text file 0001493152-22-023617.txt   20177
Mailing Address C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18 BOSTON MA 02116
Business Address
NIVEN RALPH (Reporting) CIK: 0001168060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 221181467

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations